|5.50||-0.24 / -4.18%|
As of 3:59pm ET
|5.48||-0.02 / -0.36%|
The 6 analysts offering 12-month price forecasts for MEI Pharma Inc have a median target of 14.00, with a high estimate of 16.00 and a low estimate of 9.00. The median estimate represents a +154.55% increase from the last price of 5.50.
The current consensus among 8 polled investment analysts is to Buy stock in MEI Pharma Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.